Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy

Clinical trial NCT05649163 · UNKNOWN

Trial details

NCT number: NCT05649163
Sponsor: Shen Lin
Status: UNKNOWN
Study type: OBSERVATIONAL

HER2 Advanced Gastric Cancer Advanced Gastroesophageal Junction Adenocarcinoma Advanced Solid Tumor

Start date: 2023-01-01
Primary completion: 2025-01-01
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.